Abstract

BackgroundLithospermic acid B (LAB), an active component isolated from Salvia miltiorrhiza radix, has been reported to have antioxidant effects. We examined the effects of LAB on the prevention of diabetic retinopathy in Otsuka Long-Evans Tokushima Fatty (OLETF) rats, an animal model of type 2 diabetes.Methods and FindingsLAB (10 or 20 mg/kg) or normal saline were given orally once daily to 24-week-old male OLETF rats for 52 weeks. At the end of treatment, fundoscopic findings, vascular endothelial growth factor (VEGF) expression in the eyeball, VEGF levels in the ocular fluid, and any structural abnormalities in the retina were assessed. Glucose metabolism, serum levels of high-sensitivity C-reactive protein (hsCRP), monocyte chemotactic protein-1 (MCP1), and tumor necrosis factor-alpha (TNFα) and urinary 8-hydroxy-2′-deoxyguanosine (8-OHdG) levels were also measured. Treatment with LAB prevented vascular leakage and basement membrane thickening in retinal capillaries in a dose-dependent manner. Insulin resistance and glucose intolerance were significantly improved by LAB treatment. The levels of serum hsCRP, MCP1, TNFα, and urinary 8-OHdG were lower in the LAB-treated OLETF rats than in the controls.ConclusionsTreatment with LAB had a preventive effect on the development of diabetic retinopathy in this animal model, probably because of its antioxidative effects and anti-inflammatory effects.

Highlights

  • Diabetes mellitus has shown an exponential rise of late, causing serious economic, social and health repercussions

  • Treatment with Lithospermic acid B (LAB) had a preventive effect on the development of diabetic retinopathy in this animal model, probably because of its antioxidative effects and anti-inflammatory effects

  • We investigated the effects of LAB on the occurrence of retinopathy and aimed to identify the mechanisms involved using an animal model of spontaneous diabetes

Read more

Summary

Introduction

Diabetes mellitus has shown an exponential rise of late, causing serious economic, social and health repercussions. Diabetic retinopathy is the most common microvascular complication of individuals with both type 1 and type 2 diabetes, with most patients with type 1 diabetes and more than 60% with type 2 diabetes being estimated to develop diabetic retinopathy 20 years after onset [1,2]. Its efficacy has not been completely confirmed, given that 12% of patients with diabetes under intensive treatment develop retinopathy [1,5]. We examined the effects of LAB on the prevention of diabetic retinopathy in Otsuka Long-Evans Tokushima Fatty (OLETF) rats, an animal model of type 2 diabetes

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call